Immunology Research (immunology + research)

Distribution by Scientific Domains


Selected Abstracts


Immunology highlights at high altitude: review of the fourth EAACI-GA2LEN Davos Meeting

ALLERGY, Issue 10 2006
J. Gutermuth
The field of allergy is moving fast. To keep pace with the underlying immunologic mechanisms, the 4th EAACI-GA2LEN Davos meeting on ,Basic Immunology Research in Allergy and Clinical Immunology' was organized in Grainau, Germany, February 16th,19th, 2006 by the Immunology Section of the European Academy of Allergy and Clinical Immunology and the ZAUM , Center for Allergy and Environment, Technical University Munich, with generous support from GA2LEN. Recent advances and new insights on innate and adaptive immunity, environmental factors influencing immune responses, immune regulation and allergic inflammation were presented by keynote speakers and selected participants. [source]


Establishment of T cell-specific and natural killer cell-specific unigene sets: towards high-throughput genomics of leukaemia

INTERNATIONAL JOURNAL OF IMMUNOGENETICS, Issue 6 2004
J. Illiger
Summary We report the establishment of highly non-redundant unigene sets consisting of cDNA clones derived from T lymphocytes and natural killer cells. Each set consists of 10 506 and 13 409 clones, respectively, arrayed on nylon membranes in duplicate. The sets provide an excellent tool for genome-wide gene expression analysis studies in immunology research. [source]


Molecular pathological approaches to human tumor immunology

PATHOLOGY INTERNATIONAL, Issue 4 2009
Noriyuki Sato
Research on human tumor immunology has greatly advanced in the past two decades. Many immunogenic tumor antigens have been identified, and some of these antigens entered in clinical trials. Consequently, it has been shown that these antigens can inhibit tumor growth in patients to some extent, indicating that they act as potent immunogenic therapeutic vaccines in cancer patients with malignancies originating from various tissues. These patients had antigen-specific cytotoxic T-lymphocyte (CTL) responses when assessed on tetramer, enzyme-linked immunospot (ELISPOT), T-cell clonotype and CTL induction efficiency. Thus, it has become clear that human tumor vaccines can evoke clinical and immunological anti-tumor responses in patients. The tumor regression effects of tumor vaccines, however, are generally low, and it is obvious that current vaccination protocols are generally too weak to provide substantial and satisfactory clinical benefits. This means that other drastic and more potent clinical and immunological protocols are required in cancer immunotherapy. To find such efficient protocols the basic immunological and biological properties of cancers must be investigated. In the present review the identification of human tumor antigens recognized on CTL and the clinical trials are introduced. Next, the most recent analysis of human cancer-initiating cell (cancer stem cell)-associated antigens is described. These antigens might be able to act as ,universal, general and fundamental' tumor antigens. Also present is the authors' recent study for increasing cross-presentation efficiency in dendritic cells and subsequent enhancement of human leukocyte antigen (HLA)-class I-restricted peptide antigenicity by using HSP90 and ORP150 molecular chaperones that act as endogenous Toll-like receptor ligands. In addition to the aforementioned manipulation of the positive loop of tumor immunity, it is necessary to regulate and intervene in the negative loop. In particular, the potential of the expression of HLA class I molecule regulation by epigenetic mechanisms will be discussed. Finally, the type of basic and clinical tumor immunology research highly required currently, and in the very near future, are described. [source]


Development of molecular immunoassay system for probiotics via toll-like receptors based on food immunology

ANIMAL SCIENCE JOURNAL, Issue 1 2008
Haruki KITAZAWA
ABSTRACT Recent interest has focused on the importance of intestinal immunity for the host defense, but to date, not much is known about the underlying mechanisms. The toll-like receptor (TLR) family plays an important role in host defense through recognizing bacterial pathogen-associated molecular patterns. Our recent research on the physiological function of food products has investigated the immunoregulatory effects of probiotic lactic acid bacteria (LAB) via TLR. Studies of swine, which often substitute for a human model, have demonstrated intestinal immunoregulation by the probiotic LAB mediated by TLR in the gut. On the basis of our study, efforts have also been made to develop a molecular immunoassay system for probiotic LAB and find novel immunostimulatory DNA sequences from probiotics and high potential immunobiotic LAB strains via TLR signaling. These findings may provide important clues at the molecular level on TLR signal transduction pathways and recognition mechanisms for the ligands. They also provide impetus to further delineate the activation mechanism of the innate immune response. In addition to identifying immunoregulatory factor immunogenics from LAB, a better understanding of intestinal immune regulation through cytokine networks holds out promise for basic food immunology research and the development of immunobiotic foods to prevent specific diseases. [source]